GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Omnimmune Holdings Inc (GREY:OMMH) » Definitions » 1-Year ROIIC %

Omnimmune Holdings (Omnimmune Holdings) 1-Year ROIIC % : 0.00% (As of Sep. 2010)


View and export this data going back to 2007. Start your Free Trial

What is Omnimmune Holdings 1-Year ROIIC %?

1-Year Return on Invested Incremental Capital (1-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 1-year. Omnimmune Holdings's 1-Year ROIIC % for the quarter that ended in Sep. 2010 was 0.00%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Omnimmune Holdings's 1-Year ROIIC % or its related term are showing as below:

OMMH's 1-Year ROIIC % is not ranked *
in the Biotechnology industry.
Industry Median: -5.03
* Ranked among companies with meaningful 1-Year ROIIC % only.

Omnimmune Holdings 1-Year ROIIC % Historical Data

The historical data trend for Omnimmune Holdings's 1-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Omnimmune Holdings 1-Year ROIIC % Chart

Omnimmune Holdings Annual Data
Trend May07 May08 Dec09
1-Year ROIIC %
- - -

Omnimmune Holdings Quarterly Data
May07 Aug07 Nov07 Feb08 May08 Aug08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10
1-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Omnimmune Holdings's 1-Year ROIIC %

For the Biotechnology subindustry, Omnimmune Holdings's 1-Year ROIIC %, along with its competitors' market caps and 1-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Omnimmune Holdings's 1-Year ROIIC % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Omnimmune Holdings's 1-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Omnimmune Holdings's 1-Year ROIIC % falls into.



Omnimmune Holdings 1-Year ROIIC % Calculation

Omnimmune Holdings's 1-Year ROIIC % for the quarter that ended in Sep. 2010 is calculated as:

1-Year ROIIC %=1-Year Incremental Net Operating Profit After Taxes (NOPAT)**/1-Year Incremental Invested Capital
=( -1.338 (Sep. 2010) - -1.554 (Sep. 2009) )/( 1.531 (Sep. 2010) - 1.477 (Sep. 2009) )
=0.216/0.054
=400.00%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of NOPAT and Invested Capital was used to calculate 1-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Omnimmune Holdings  (GREY:OMMH) 1-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Omnimmune Holdings 1-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Omnimmune Holdings's 1-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Omnimmune Holdings (Omnimmune Holdings) Business Description

Traded in Other Exchanges
N/A
Address
4600 Post Oak Place, Suite 352, Houston, TX, USA, 77027
Website
Omnimmune Holdings Inc is a development-stage biotechnology company, which is engaged in integrating complementary cancer therapeutic, diagnostic and prognostic technologies.

Omnimmune Holdings (Omnimmune Holdings) Headlines

No Headlines